Pulse Survey

Quote

anonymous said:
Y’all are a pathetic bunch of bitches. This company paid you for a year with no sales, step up or step out.
Click to expand...
Let’s be clear: the truly pathetic ones are those who’ve been getting paid handsomely for years—collecting hundreds of thousands in LTi each year—while leading others to believe they knew what they were doing. They’re the same ones who thought people still wore suits and ties in hospitals. We didn’t create this dumpster fire—we inherited it. Lets get some real leadership.
 






I wonder how "honest" people were in their comments this time? And will there be retaliation for those who spoke the truth? It's clear they'll know who you are. People are very upset with the same issues. It should wake Leadership up. Let's see if it does.
 




I was sure honest. It’s a last ditch effort to see if leadership will indeed wake up and listen. They hired experienced professionals and treat everyone like children. There needs to be a major overhaul in the pain division from payor access to marketing and sales leadership or this launch will continue to march quickly toward failure.
 


anonymous said:
I was sure honest. It’s a last ditch effort to see if leadership will indeed wake up and listen. They hired experienced professionals and treat everyone like children. There needs to be a major overhaul in the pain division from payor access to marketing and sales leadership or this launch will continue to march quickly toward failure.
Click to expand...
Agreed
 


Y’all are talking about puttin lipstick on a pig.
Published clinical data showing no better than Tylenol for chronic pain is the problem. No leadership on the planet can fix that. Quit pointing the finger at the wrong excuse, it shows ignorance and immaturity.
 


anonymous said:
Y’all are talking about puttin lipstick on a pig.
Published clinical data showing no better than Tylenol for chronic pain is the problem. No leadership on the planet can fix that. Quit pointing the finger at the wrong excuse, it shows ignorance and immaturity.
Click to expand...
Link the study that shows that, doesn’t exist

Secondly who is talking about chronic. Typical troll that doesn’t even work here
 


While Journavx has shown promise in managing acute pain, its efficacy in chronic pain conditions remains under investigation. A Phase 2 study focusing on lumbosacral radiculopathy (lower back pain) did not demonstrate a significant benefit over placebo, highlighting the challenges in treating chronic pain and the need for further research.



In summary, Journavx is not very impressive. It has a weak pain killing strength and is effective only in acute surgical pain and not for chronic pain. As with any medication, it is essential to weigh its benefits against potential risks and to consider individual patient needs when determining the most appropriate pain management strategy.
 


The current data on lumbar radiculopathy has not been fully released yet (it is still in Phase 2 studies). The data released so far was pretty underwhelming; the drug performed the same as placebo for change in numerical pain rating scale from baseline to 12 weeks (Journavx -2.02 vs placebo -1.98, P < 0.0001). This study duration barely meets the technical CDC criteria for chronic pain, which is pain lasting ≥ 3 months. Without stronger data, it seems we are grasping at straws because it is a non-opioid.
 

















Write your reply...
Top Bottom
Back
Quote